Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 25, 2010

View Archived Issues

Emory University discloses new subunit-selective NMDA receptor agonists

KPT-127 inhibits tumor growth in vivo in xenograft model

TAK-438 shows promise to treat acid-related diseases

MannKind provides Afrezza for Artificial Pancreas Project

Bayer Schering claims new adenosine A1 receptor agonists

NeuroSearch presents new modulators of nicotinic acetylcholine receptors

Phase IIb data support use of tasocitinib as immunosuppressant in kidney transplant recipients

Roche and Aileron Therapeutics join to develop stapled peptide drugs

FDA clears Prolor Biotech's IND for phase II trial of hGH-CTP

Daiichi Sankyo presents new cyclic amino alcohols for autoimmune conditions

New GlyT-1 inhibitors described by AstraZeneca

New hepatocyte growth factor receptor inhibitors claimed by sanofi-aventis

Raptor Pharmaceuticals provides clinical program update

Isotechnika and 3SBio sign agreement for voclosporin in China

FDA grants fast track status to ThermoDox for HCC

Vyteris to license Georgia Tech's transdermal drug delivery technologies

Cerus regains commercial rights to Intercept blood system from BioOne

Cellonis reports on use of stem cell therapy to treat child with diabetes

Strativa launches Oravig in U.S. for oropharyngeal candidiasis

Human neural stem cell transplants restore function in model of chronic spinal cord injury

Daiichi requests approval to manufacture and market denosumab in Japan

Clinuvel plans pilot trial of Scenesse in vitiligo

Upsher-Smith acquires U.S. marketing rights to Vagifem 10 mcg

Taligen Therapeutics advances TT30 program

Synta Pharma begins phase I trial of STA-9090/docetaxel combination

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...